Screener
Arcus Biosciences RCUS Other Non-Current Liabilities
Other Non-Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Arcus Biosciences in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.
The source filing: Arcus Biosciences’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001724521-26-000044
FAQ
- What is Arcus Biosciences's other non-current liabilities?
- Arcus Biosciences (RCUS) reported other non-current liabilities of $124M in Q2 2026.
- How has Arcus Biosciences's other non-current liabilities changed year-over-year?
- Arcus Biosciences's other non-current liabilities decreased by 22.0% year-over-year, from $159M to $124M.
- What is the long-term trend for Arcus Biosciences's other non-current liabilities?
- Over 5 years (2020 to 2025), Arcus Biosciences's other non-current liabilities has grown at a 201.4% compound annual growth rate (CAGR), from $543K to $135M.
- What does other non-current liabilities mean?
- Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.
Ask your AI about Arcus Biosciences's other non-current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude